Coupang Keeps Overweight Rating as Barclays Cuts Target to $29, Market Cap $33.26B
CPNG•Coupang’s market capitalization stands at $33.26 billion and Barclays reaffirmed its Overweight rating while trimming the price target to $29 from $30 as shares trade near $18.50. Fifteen brokerages rate the stock with an average 1.97 score—eight Strong Buys and one Buy—while regulatory scrutiny mounts in South Korea.
1. Barclays Maintains Overweight Rating
On July 7 Barclays reaffirmed its Overweight rating on the stock and reduced the price target to $29 from $30. An Overweight rating indicates expectations for the stock to outperform the broader market in coming months.
2. Wall Street Consensus Remains Bullish
Fifteen brokerage firms contribute to an average recommendation score of 1.97 on a 1 (Strong Buy) to 5 (Strong Sell) scale, with eight firms issuing Strong Buy opinions and one firm issuing a Buy. This widespread confidence underscores optimistic expectations for future performance.
3. Market Capitalization and Trading Range
Coupang’s shares trade around $18.50, reflecting a market capitalization of $33.26 billion. Over the past 52 weeks, shares have ranged between $14.92 and $34.08, highlighting recent volatility.
4. Regulatory Challenges in South Korea
A U.S. House Judiciary Committee report alleges that South Korean authorities have discriminated against the U.S.-based company. This regulatory scrutiny could influence operational approvals and weigh on investor sentiment moving forward.
